Supplementary Figure 4 from FcRL5 as a Target of Antibody–Drug Conjugates for the Treatment of Multiple Myeloma (original) (raw)
Preclinical Development FcRL 5 as a Target of Antibody – Drug Conjugates for the Treatment of Multiple Myeloma
Andrew Polson
2012
View PDFchevron_right
FcRL5 as a Target of Antibody-Drug Conjugates for the Treatment of Multiple Myeloma
Maryann Go, Suzie Scales, Kristi Elkins
View PDFchevron_right
Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma
Douglas Leipold
Blood Cancer Journal, 2019
View PDFchevron_right
Emerging Role of Antibody-Drug Conjugates and Bispecific Antibodies for the Treatment of Multiple Myeloma
Diana Franco
Antibodies, 2022
View PDFchevron_right
Investigational Monoclonal Antibodies in the Treatment of Multiple Myeloma: A Systematic Review of Agents under Clinical Development
Nimra Iftikhar
Antibodies, 2019
View PDFchevron_right
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma
Alessandro Allegra
European Journal of Haematology, 2013
View PDFchevron_right
Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf
Rita Rizzi
Pharmaceuticals, 2021
View PDFchevron_right
Monoclonal antibody therapy in multiple myeloma: where do we stand and where are we going?
Shmuel Yaccoby
Immunotherapy, 2016
View PDFchevron_right
Monoclonal antibodies in the treatment of multiple myeloma
Beth Faiman
British Journal of Haematology, 2011
View PDFchevron_right
A phase 1 dose-escalation study of antibody BI-505 in relapsed/refractory multiple myeloma
Peter Gimsing
Clinical Cancer Research, 2015
View PDFchevron_right
Data from A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma
Titti Niskanen
View PDFchevron_right
CS1, a Potential New Therapeutic Antibody Target for the Treatment of Multiple Myeloma
Bart Barlogie
Clinical Cancer Research, 2008
View PDFchevron_right
Supplemental table 1 from A Phase I Dose-Escalation Study of Antibody BI-505 in Relapsed/Refractory Multiple Myeloma
Markus Hansson
View PDFchevron_right
Targeted therapies in multiple myeloma
Andreas Charidimou
Targeted oncology, 2009
View PDFchevron_right
The prospects and promise of chimeric antigen receptor immunotherapy in multiple myeloma
Antonia Rotolo
British journal of haematology, 2016
View PDFchevron_right
Antibody-drug conjugate targeting CD46 eliminates multiple myeloma cells
Diego Acosta-Alvear
The Journal of clinical investigation, 2016
View PDFchevron_right
Encouraging Debut of Immunotherapy In Myeloma
Nahla Hamed
Cancer therapy & oncology international journal, 2016
View PDFchevron_right
The Role of Targeted Therapy in Multiple Myeloma
Silvia Ling
Resistance to Targeted Anti-Cancer Therapeutics, 2021
View PDFchevron_right
Targeting CD205 with the antibody drug conjugate MEN1309/OBT076 is an active new therapeutic strategy in lymphoma models
Alessio Fiascarelli
Haematologica, 2020
View PDFchevron_right
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)
Ingemar Turesson
Leukemia, 2013
View PDFchevron_right
Immunomodulatory drugs in multiple myeloma: from molecular mechanisms of action to clinical practice
Roberto Castelli
Immunopharmacology and immunotoxicology, 2012
View PDFchevron_right
Novel Approaches Outside the Setting of Immunotherapy for the Treatment of Multiple Myeloma: The Case of Melflufen, Venetoclax, and Selinexor
Rita Rizzi
Frontiers in Oncology, 2021
View PDFchevron_right
Immunotherapy in Multiple Myeloma
Tajana Grenko
Frontiers Research Topics, 2019
View PDFchevron_right
Immunotherapy of Multiple Myeloma With a Monoclonal Antibody Directed Against a Plasma Cell-Specific Antigen, HM1.24
Toshio Matsumoto
Blood, 1997
View PDFchevron_right
Preclinical evidence for the therapeutic potential of CD38-targeted immuno-chemotherapy in multiple myeloma patients refractory to lenalidomide and bortezomib
Niels van de Donk, Richard Groen, Anton Martens
Clinical cancer research : an official journal of the American Association for Cancer Research, 2014
View PDFchevron_right